Nephrocare Health Services Limited has notified stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, bearing reference number NEPHROPLUS/SE/030, was issued on May 04, 2026, and addressed to both BSE Limited and the National Stock Exchange of India Limited.

Board Meeting Details

The Board meeting is scheduled to be held on Tuesday, May 19, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended March 31, 2026.

Key details of the board meeting intimation are summarised below:

Trading Window Closure

In accordance with the applicable insider trading regulations and further to the company's earlier intimation dated March 25, 2026, the trading window for dealing in the securities of the company has been closed. The closure applies to all designated persons and their immediate relatives.

The intimation was signed by Kishore Kathri, Company Secretary & Compliance Officer (ICSI M. No. F9895), on behalf of Nephrocare Health Services Limited, formerly known as Nephrocare Health Services Private Limited.

Nephrocare Health Services Limited has announced the designation of Mr. Prashant Vinodkumar Goenka as Chief Risk Officer (CRO), effective April 03, 2026. The healthcare services company informed stock exchanges about this key leadership appointment through a regulatory filing under SEBI Listing Regulations.

Board Approval and Designation Details

The Board of Directors approved the designation through a circular resolution dated April 03, 2026. Mr. Goenka, who currently serves as the Chief Financial Officer, will take on the additional role of Chief Risk Officer while continuing his existing responsibilities. The appointment aligns with regulatory requirements under SEBI Listing Regulations and related master circulars.

Professional Background and Expertise

Mr. Prashant Vinodkumar Goenka has been associated with Nephrocare Health Services since May 7, 2024, leading finance, strategy, administration, secretarial, and technology functions. His educational credentials include a bachelor's degree in engineering (electrical and electronics) with honors and a master's degree in science (economics) with honors from Birla Institute of Technology and Science, Pilani.

He further enhanced his qualifications with a master's of business administration from the University of Chicago, Booth School of Business, focusing on finance and strategic management. As a certified Six Sigma Master Black Belt, Mr. Goenka brings specialized expertise in process optimization and quality management.

Industry Experience and Leadership

Mr. Goenka's professional journey spans over 20 years in financial services, with extensive experience across international markets. His career includes leadership roles with prominent financial institutions:

• HSBC: Senior leadership positions
• Bank of America: Strategic roles in financial services
• JP Morgan Chase: Expertise in banking operations

His diverse experience covers operations across the USA, Philippines, and India, providing him with a global perspective on financial risk management and regulatory compliance.

Regulatory Compliance and Disclosure

The appointment fulfills regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30. The company has made the disclosure available on its official website at www.nephroplus.com , ensuring transparency for stakeholders and investors.

The designation strengthens Nephrocare Health Services' risk management framework by leveraging Mr. Goenka's extensive financial services background and international experience in the healthcare sector.